Trial Profile
To compare platelet function activity in Chronic lymphocytic leukemia versus Mantle cell lymphoma patients before initiation of Ibrutinib treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jan 2017
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia; Mantle-cell lymphoma
- Focus Therapeutic Use
- 25 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology